Director/PDMR Shareholding

RNS Number : 7106S

Smith & Nephew Plc

17 November 2021

 

SMITH & NEPHEW PLC

17 November 2021

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.

On 16 November 2021, Smith+Nephew was notified that the following awards of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") vested under the Smith & Nephew Global Share Plan 2010.

1.  FINAL VESTING ON 13 NOVEMBER 2021 OF A CONDITIONAL SHARE AWARD MADE UNDER THE GLOBAL SHARE PLAN 2010:

The award was granted under the Global Share Plan 2010 on 13 November 2018. One third of the shares vested on 13 November 2019, a further third vested on 13 November 2020 and the final third vested on 13 November 2021. A number of Shares were sold to cover taxation obligations arising on the vesting of the awards.

The following relates to individuals included in the below notification:

Reason for the notification
Initial notification /Amendment	Initial notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name	Smith & Nephew plc
LEI	213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument	Smith & Nephew plc ordinary shares of USD 0.20 each
Identification code	ISIN: GB0009223206
Nature of the transaction	Final vesting of a Conditional Share Award granted on 13 November 2018 under the Smith & Nephew Global Share Plan 2010.
Date of Transaction	2021 - 11 - 15
Place of Transaction	London Stock Exchange (XLON)

Name (Position)	Director / PDMR	Price	Volume	Aggregated information	Total Ordinary Share Holding following the transaction *	Total Ordinary Share Holding as a % of the Company's ISC following the transaction *
Skip Kiil (President Orthopaedics)	PDMR	£13.105	18,351 (of which 7,247 were sold and 11,104 retained)	N/A Single Transaction	23,306.12693 ordinary shares	0.00263%

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

2.  SKIP KIIL - SALE OF ORDINARY SHARES

Reason for the notification
Initial notification /Amendment	Initial notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name	Smith & Nephew plc
LEI	213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument	Smith & Nephew plc ordinary shares of USD 0.20 each
Identification code	ISIN: GB0009223206
Nature of the transaction	Sale of ordinary shares.
Date of Transaction	2021 - 11 - 16
Place of Transaction	London Stock Exchange (XLON)

Name (Position)	Director / PDMR	Price (£)	Volume	Aggregated information	Total Ordinary Share Holding following the transaction *	Total Ordinary Share Holding as a % of the Company's ISC following the transaction *
Skip Kiil (President Orthopaedics)	PDMR	13.124612	23,306	N/A Single Transaction	0.12693 ordinary shares	0.00000%

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

Susan Swabey  

Company Secretary

Smith & Nephew plc

Tel: [phone]

 

END

 

 

DSHFLFSVLDLDLIL